About CentraState Healthcare System
CentraState Healthcare System is a non-profit community health organization consisting of an acute-care hospital, an ambulatory care campus, three senior living communities, a Family Medicine Residency Program, and a charitable foundation. It is a member of the Robert Wood Johnson Health Network and a clinical research affiliate of The Cancer Institute of New Jersey, a National Cancer Institute-designated Comprehensive Cancer Center. For more information, visit www.centrastate.com
Ad Statistics
Times Displayed: 45539
Times Visited: 1299 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
About Princeton Radiation Oncology
Princeton Radiation Oncology (PRO), a division of Princeton Radiology Associates PA, is a 10-physician group of board certified radiation oncologists who practice at five accredited cancer centers in New Jersey and Pennsylvania. The radiation oncologists, together with their team of specialized physicists, dosimetrists, therapists, and nurses, provide patients with an array of advanced cancer treatments in an intimate, patient-centered environment. PRO physicians are respected leaders in their field, having trained in and served on the faculties of some of the most prestigious institutions in the country. All have published literature in radiation oncology and many have been named as Top Doctors by their peers. A number of the PRO physicians have personal experience with advanced proton therapy from their training at Harvard's Massachusetts General Hospital.
Princeton Radiology Associates (PRA) is a 33 physician group practice which provides diagnostic radiology services at one hospital and four imaging centers in central New Jersey, as well as radiation oncology services through PRO. In addition to providing direct patient care, the physicians of PRA established a research division, Princeton Radiology Pharmaceutical Research (RadPharm), which is now an internationally recognized leader in the evaluation of the efficacy of novel pharmaceutical agents for the treatment of cancer and other diseases.
For more information, visit www.princetonradiationoncology.com
Back to HCB News
